Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases

Human Pathology(2024)10.1016/j.humpath.2024.04.012Source: DataRank Database

Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases is a research paper published in Human Pathology (2024). On theSindex it has a DataRank of 0. It has been cited 8 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access8 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.75)OA: greenTopics (61)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Hui Chen ORCID,Jianping Zhao ORCID,Sinchita Roy‐Chowdhuri ORCID,Ashish M. Kamat ORCID,Omar Alhalabi ORCID

Live enrichment

PubMed:38679207 PMC:PMC11755388 OpenAlex:https://openalex.org/W4395669789

National Cancer Institute

Grant: P30 CA016672

University of California

Grant: PIK3CA

University of California

Grant: 13,16

University of California

Grant: PIK3C2G

National Institutes of Health

FWCI

3.75

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC11755388/pdf/nihms-2046177.pdf

publisherhttps://api.elsevier.com/content/article/PII:S0046817724000649?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0046817724000649?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11755388

Fields of Study

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesViral-associated cancers and disordersMedicineHumansMaleAgedMiddle AgedFemaleUrinary Bladder NeoplasmsAdultAged, 80 and overMutationBiomarkers, TumorDNA Copy Number VariationsDNA Mutational AnalysisImmunohistochemistryTOR Serine-Threonine KinasesUrotheliumIn Situ Hybridization, FluorescenceTumor Suppressor Protein p53TelomeraseCarcinoma, Transitional CellErb-b2 Receptor Tyrosine KinasesGenetic Predisposition to Disease

MeSH Terms

AdultAgedAged, 80 and overUrinary Bladder NeoplasmsCarcinoma, Transitional CellDNA Mutational AnalysisFemaleHumansImmunohistochemistryMaleMiddle AgedMutationBiomarkers, TumorTumor Suppressor Protein p53In Situ Hybridization, FluorescenceReceptor, ErbB-2Erb-b2 Receptor Tyrosine KinasesTelomeraseUrotheliumGenetic Predisposition to DiseaseDNA Copy Number VariationsTOR Serine-Threonine Kinases

Keywords

Urothelial carcinomaUrinary bladderCarcinomaUrinary systemUrologyMedicinePathologyInternal medicineBladder cancerCancergene mutationsMtorNext-generation SequencingPlasmacytoid Urothelial Carcinoma

Plasmacytoid urothelial carcinoma of the urinary bladder–A clinicopathological and molecular analysis of 52 cases

FAIR Checklist

Authors (11)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)